Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura - Contacts and Locations

Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura (ITP)

This study has been completed.

Study NCT00699140. Last updated on June 20, 2008. Information provided by Grifols Biologicals Inc.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00699140

Locations


Russian Federation
	Botkin City Clinical Hospital
	Moscow, Russian Federation
	Haematology Research Centre of Russian Academy of Medical Science
	Moscow, Russian Federation

Spain
	Hospital Clínic i Provincial
	Barcelona, Spain
	Hospital General Universitario La Paz
	Madrid, Spain
	Hospital de la Santa Creu i Sant Pau
	Barcelona, Spain
	Hospital Universitario de Salamanca
	Salamanca, Spain
	Hospital General Vall d´Hebron
	Barcelona, Spain
	Hospital Doce de Octubre
	Madrid, Spain
	Hospital Universitario La Fe
	Valencia, Spain
	. Hospital de León
	Leon, Spain
	Hospital de Bellvitge
	Barcelona, Spain

Sponsors and Collaborators

Grifols Biologicals Inc.

Investigators


Study Chair:	Antonio Julia, MD	Hospital General Vall Hebron